CanaryIQ uses privacy-friendly, cookieless analytics (Fathom) to understand aggregate site usage. We don't use tracking cookies, we don't sell or share your data, and we respect Global Privacy Control. See our Privacy Policy.

Know what technology will do to your business, and when

CanaryIQ publishes predictions about where technology is heading over the next ten years. Each one says what most people think, what we think, and what it means for businesses. Use them to plan spending, suppliers and hiring.

Predictions.

Know what could go wrong

We follow the risks to these technologies, from a blockade of Taiwan to a shortage of power for data centres. For each one we say how likely it is and what it would hit. Some are already happening.

The constraint is outside the server rack
4–8years

to build new transmission lines
in advanced economies

Planning question: does the infrastructure timetable fit the deployment timetable?

Short enough to read before a meeting

Each prediction gives you the headline, what most people think and what we think. Our research on 235 technologies, and the patents, papers and filings behind it, is there when you want more.

A policy change becomes a business question
SubjectAI-generated content
ContextEU AI Act · transparency

Where does your product need to disclose AI use?

Map the relevant customer interactions and content types before deciding what the interface needs to communicate.

Review withProduct · Legal · Engineering

Follow the technologies that affect you

Choose the technologies that matter to your business. We show you the latest news on them, and whether it supports or counts against each prediction.

CRISPR crosses a regulatory threshold
DEC082023

CASGEVY

FDA approval for sickle cell disease in patients aged 12 and older with recurrent vaso-occlusive crises.

CRISPR/Cas9 gene editing

A second FDA indication: transfusion-dependent β-thalassemia, ages 12 and older.

Read our full view on every prediction